Tiziana is an England-based biotechnology company that develops and commercializes transformative drugs for the treatment of neurodegenerative and gastrointestinal diseases.
Business Model:
Revenue: $8.6M
Employees: 2-10
Address: 55 Park Lane
City: London
State: england
Zip: W1K 1NA
Country: GB
Tiziana is an England-based biotechnology company that develops and commercializes transformative drugs for the treatment of neurodegenerative and gastrointestinal diseases.
Contact Phone:
Contact Email:
Listed Exchange:
London Stock Exchange
IPO Date:
11/19/2018
Ticker Symbol:
TILS
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2022 | AccuStem Sciences | Post-IPO Equity | 0 |
4/2022 | AccuStem Sciences | Post-IPO Equity | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2019 | Convertible Note | $1.9M | 9/2022 | Grant | 1 | - |
The ALS Association The ALS Association |
1/2018 | Private Placement | $268.6k | 12/2015 | Equity | $5.8M | 9/2022 | Grant | 1 | - |
The ALS Association The ALS Association |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|